Free Trial
NASDAQ:WGS

GeneDx Q2 2025 Earnings Report

GeneDx logo
$79.83 -1.62 (-1.99%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$79.91 +0.08 (+0.10%)
As of 07/25/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GeneDx EPS Results

Actual EPS
N/A
Consensus EPS
$0.09
Beat/Miss
N/A
One Year Ago EPS
N/A

GeneDx Revenue Results

Actual Revenue
N/A
Expected Revenue
$86.00 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

GeneDx Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, July 29, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

GeneDx Earnings Headlines

GeneDx CFO Sells More Than Half of His Shares
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
See More GeneDx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GeneDx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GeneDx and other key companies, straight to your email.

About GeneDx

GeneDx (NASDAQ:WGS), through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

View GeneDx Profile

More Earnings Resources from MarketBeat